132 related articles for article (PubMed ID: 1282924)
1. Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers.
Tsuji T; Sasaki K; Kimura Y; Yamada K; Mori M; Shinozaki F
Int J Oral Maxillofac Surg; 1992 Dec; 21(6):369-72. PubMed ID: 1282924
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
Zoeller J; Flentje M; Sinn P; Born IA
Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
[TBL] [Abstract][Full Text] [Related]
3. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
4. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
5. Alteration of argyrophilic nucleolar organizer region associated (Ag-NOR) proteins in apoptosis-induced human salivary gland cells and human oral squamous carcinoma cells.
Morimoto Y; Kito S; Ohba T; Morimoto H; Okamura H; Haneji T
J Oral Pathol Med; 2001 Apr; 30(4):193-9. PubMed ID: 11302237
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study.
Tsuji T; Shrestha P; Yamada K; Takagi H; Shinozaki F; Sasaki K; Maeda K; Mori M
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):377-83. PubMed ID: 1375793
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer.
Lörz M; Meyer-Breiting E; Bettinger R
Eur Arch Otorhinolaryngol; 1994; 251(2):91-4. PubMed ID: 7517683
[TBL] [Abstract][Full Text] [Related]
8. PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma.
Costa Ade L; de Araújo NS; Pinto Ddos S; de Araújo VC
J Oral Pathol Med; 1999 Nov; 28(10):438-41. PubMed ID: 10551740
[TBL] [Abstract][Full Text] [Related]
9. [Proliferating cell nuclear antigen (PCNA) in oral leukoplakia].
Qiao B; Yu S; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jul; 30(4):210-1. PubMed ID: 8745441
[No Abstract] [Full Text] [Related]
10. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma.
Chattopadhyay A; Chawda JG; Doshi JJ
Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):374-7. PubMed ID: 7699280
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
12. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
[TBL] [Abstract][Full Text] [Related]
13. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
[TBL] [Abstract][Full Text] [Related]
14. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinoma - an aid to conventional histological grading?
Zain RB; Sakamoto F; Shrestha P; Mori M
Malays J Pathol; 1995 Jun; 17(1):23-30. PubMed ID: 8907001
[TBL] [Abstract][Full Text] [Related]
18. Identification of the AgNORs, PCNA and ck16 proteins in oral lichen planus lesions.
da Silva Fonseca LM; do Carmo MA
Oral Dis; 2001 Nov; 7(6):344-8. PubMed ID: 11834097
[TBL] [Abstract][Full Text] [Related]
19. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
20. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease.
Baum HP; Meurer I; Unteregger G
Br J Dermatol; 1994 Aug; 131(2):231-6. PubMed ID: 7917988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
